143 related articles for article (PubMed ID: 35869699)
1. From functional genomics of vero cells to CRISPR-based genomic deletion for improved viral production rates.
Sène MA; Xia Y; Kamen AA
Biotechnol Bioeng; 2022 Oct; 119(10):2794-2805. PubMed ID: 35869699
[TBL] [Abstract][Full Text] [Related]
2. Integrated CRISPR-Cas9 System-Mediated Knockout of IFN-γ and IFN-γ Receptor 1 in the Vero Cell Line Promotes Viral Susceptibility.
Kim S; Nowakowska A; Kim YB; Shin HY
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897807
[TBL] [Abstract][Full Text] [Related]
3. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures.
Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA
Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures.
Mangion M; Gélinas JF; Bakhshi Zadeh Gashti A; Azizi H; Kiesslich S; Nassoury N; Chahal PS; Kobinger G; Gilbert R; Garnier A; Gaillet B; Kamen A
Vaccine; 2020 Nov; 38(50):7949-7955. PubMed ID: 33139138
[TBL] [Abstract][Full Text] [Related]
5. Enhancing viral vaccine production using engineered knockout vero cell lines - A second look.
Hoeksema F; Karpilow J; Luitjens A; Lagerwerf F; Havenga M; Groothuizen M; Gillissen G; Lemckert AAC; Jiang B; Tripp RA; Yallop C
Vaccine; 2018 Apr; 36(16):2093-2103. PubMed ID: 29555218
[TBL] [Abstract][Full Text] [Related]
6. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro.
Vasques Raposo J; Rodrigues Carvalho Barros L; Ribas Torres L; Barbosa da Silva Pinto R; De Oliveira Lopes A; Mello de Souza E; Hernan Bonamino M; Salete de Paula V
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):19-23. PubMed ID: 37715442
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase.
Chan CP; Yuen CK; Cheung PH; Fung SY; Lui PY; Chen H; Kok KH; Jin DY
FASEB J; 2018 Aug; 32(8):4380-4393. PubMed ID: 29513570
[TBL] [Abstract][Full Text] [Related]
9. Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication.
Chia BS; Li B; Cui A; Eisenhaure T; Raychowdhury R; Lieb D; Hacohen N
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878895
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of JIP4 at S730 Presents Antiviral Properties against Influenza A Virus Infection.
Del Sarto J; Gerlt V; Friedrich ME; Anhlan D; Wixler V; Teixeira MM; Boergeling Y; Ludwig S
J Virol; 2021 Sep; 95(20):e0067221. PubMed ID: 34319782
[TBL] [Abstract][Full Text] [Related]
11. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME; Haslwanter D; Bortz RH; Wirchnianski AS; Lasso G; Vergnolle O; Abbasi SA; Fels JM; Laudermilch E; Florez C; Mengotto A; Kimmel D; Malonis RJ; Georgiev G; Quiroz J; Barnhill J; Pirofski LA; Daily JP; Dye JM; Lai JR; Herbert AS; Chandran K; Jangra RK
Cell Host Microbe; 2020 Sep; 28(3):486-496.e6. PubMed ID: 32738193
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide CRISPR Screen Identifies RACK1 as a Critical Host Factor for Flavivirus Replication.
Shue B; Chiramel AI; Cerikan B; To TH; Frölich S; Pederson SM; Kirby EN; Eyre NS; Bartenschlager RFW; Best SM; Beard MR
J Virol; 2021 Nov; 95(24):e0059621. PubMed ID: 34586867
[TBL] [Abstract][Full Text] [Related]
13. High-efficiency targeted editing of large viral genomes by RNA-guided nucleases.
Bi Y; Sun L; Gao D; Ding C; Li Z; Li Y; Cun W; Li Q
PLoS Pathog; 2014 May; 10(5):e1004090. PubMed ID: 24788700
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
[TBL] [Abstract][Full Text] [Related]
15. A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus Infection.
Labeau A; Simon-Loriere E; Hafirassou ML; Bonnet-Madin L; Tessier S; Zamborlini A; Dupré T; Seta N; Schwartz O; Chaix ML; Delaugerre C; Amara A; Meertens L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915280
[TBL] [Abstract][Full Text] [Related]
16. A system for production of defective interfering particles in the absence of infectious influenza A virus.
Bdeir N; Arora P; Gärtner S; Hoffmann M; Reichl U; Pöhlmann S; Winkler M
PLoS One; 2019; 14(3):e0212757. PubMed ID: 30822349
[TBL] [Abstract][Full Text] [Related]
17. RNA interference targeting virion core protein ORF095 inhibits Goatpox virus replication in Vero cells.
Zhao Z; Wu G; Zhu X; Yan X; Dou Y; Li J; Zhu H; Zhang Q; Cai X
Virol J; 2012 Feb; 9():48. PubMed ID: 22340205
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
Saito K; Shimasaki K; Fukasawa M; Suzuki R; Okemoto-Nakamura Y; Katoh K; Takasaki T; Hanada K
Virus Res; 2022 Dec; 322():198935. PubMed ID: 36152929
[TBL] [Abstract][Full Text] [Related]
19. Vector derived artificial miRNA mediated inhibition of West Nile virus replication and protein expression.
Karothia D; Kumar Dash P; Parida M; Bhagyawant SS; Kumar JS
Gene; 2020 Mar; 729():144300. PubMed ID: 31884102
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
